|
End-of-day quote
Shenzhen S.E.
30/10/2026
|
5-day change | 1st Jan Change | ||
| 4.340 CNY | +0.23% |
|
-3.34% | -16.86% |
| Market Cap | 6.19B 930M 833M 767M 695M 1.3B 88.35B 1.32B 9.14B 3.67B 46.47B 3.49B 3.42B 147B | P/E 2024 |
18.2x | P/E 2025 | 29x |
|---|---|---|---|---|---|
| Enterprise Value | 4.7B 707M 633M 582M 527M 986M 67.08B 1B 6.94B 2.79B 35.29B 2.65B 2.6B 111B | EV / Sales 2024 |
0.62x | EV / Sales 2025 | 0.84x |
| Free-Float |
39.09% | Yield 2024 |
1.9% | Yield 2025 | 1.05% |
| 17/03/23 | China Monthly Antitrust Update - March 2023 | AQ |
| 1 day | +0.23% | ||
| 1 week | -3.34% | ||
| Current month | -8.82% | ||
| 1 month | -8.82% | ||
| 3 months | -4.82% | ||
| 6 months | -11.97% | ||
| Current year | -16.86% |
| 1 week | 4.27 |  | 4.54 |
| 1 month | 4.27 | | 5.07 |
| Current year | 4.09 | | 5.73 |
| 1 year | 4.09 | | 5.93 |
| 3 years | 3.72 | | 6.69 |
| 5 years | 3.72 | | 9.3 |
| 10 years | 3.72 | | 9.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yong Gang Cai
CEO | Chief Executive Officer | 46 | 20/01/2025 |
Xin Li
DFI | Director of Finance/CFO | 46 | 05/09/2025 |
Dong Sheng Yan
IRC | Investor Relations Contact | 42 | 30/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Kai Zhou
CHM | Chairman | 62 | 20/01/2025 |
Xin Hua Ao
BRD | Director/Board Member | 62 | 17/07/2018 |
Cheng Ren Huang
BRD | Director/Board Member | 62 | 17/07/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.23% | -3.34% | -20.66% | -20.80% | 930M | |
| +3.19% | +11.31% | +67.86% | +150.58% | 1,263B | |
| -0.73% | +3.56% | +44.51% | +85.81% | 658B | |
| +1.41% | +3.24% | +29.22% | +107.83% | 521B | |
| +0.42% | +3.20% | +54.15% | +67.18% | 391B | |
| +2.18% | +2.93% | +73.30% | +45.62% | 369B | |
| +1.12% | +4.52% | +35.30% | +58.08% | 307B | |
| +6.96% | +8.86% | +11.27% | +36.62% | 290B | |
| +1.15% | +6.09% | +59.59% | +77.06% | 252B | |
| +3.06% | +9.38% | +44.11% | +119.47% | 212B | |
| Average | +1.58% | +4.93% | +39.86% | +72.74% | 426.29B | |
| Weighted average by Cap. | +1.19% | +6.60% | +50.86% | +98.29% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7.5B 1.13B 1.01B 929M 841M 1.57B 107B 1.6B 11.07B 4.45B 56.3B 4.23B 4.14B 178B | 7.07B 1.06B 952M 876M 793M 1.48B 101B 1.51B 10.44B 4.19B 53.09B 3.99B 3.9B 167B |
| Net income | 410M 61.58M 55.15M 50.73M 45.96M 85.92M 5.85B 87.53M 605M 243M 3.08B 231M 226M 9.7B | 260M 39.07M 34.99M 32.19M 29.17M 54.52M 3.71B 55.54M 384M 154M 1.95B 147M 144M 6.15B |
| Net Debt | -2.88B -432M -387M -356M -323M -603M -41.03B -614M -4.24B -1.7B -21.58B -1.62B -1.59B -68.06B | -1.49B -224M -201M -184M -167M -312M -21.26B -318M -2.2B -883M -11.19B -840M -823M -35.27B |
Employees
5,727
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | CN¥4.340 | +0.23% | 9,923,168 |
| 29/10/26 | CN¥4.330 | -1.59% | 8,593,911 |
| 28/10/26 | CN¥4.400 | 0.00% | 7,708,744 |
| 27/10/26 | CN¥4.400 | -2.44% | 7,499,900 |
| 26/10/26 | CN¥4.510 | +0.45% | 7,090,523 |
- Stock Market
- Stocks
- 000597 Stock
Select your edition
All financial news and data tailored to specific country editions
